Institutes of Biomedical Research Corp (MRES)

[StockHobit]

Neuro-Biotech Corp.business aims are to: develop and commercialize quantitative diagnostic blood tests for early diagnosis, monitoring and
follow-up for a large range of neuroscience and stress related disorders in order to accommodate unsatisfied medical needs; develop its own
extensive portfolio of diagnostic tests and natural brain neuroceuticals; enter into strategic alliances with large distributors in order to accelerate
its worldwide market penetration in general and, in particular some revenue interesting niche markets, by initiating sales through its own sales
force; and by forming business partnerships with private laboratory networks on a worldwide basis.
The Company on December 30, 2010, entered into a ten-year sublicense agreement with Credo-TM, a Russian company to distribute the
Company’s patented products in the Russian Federation as defined in the agreement. Under the agreement, Credo-TM agrees to purchase
500,000 units at an agreed upon price of $55.